Institutionelle bei Abgenix

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Taunus Corporation 3,341,821 $27,269,259
JP Morgan Chase & Company 3,034,557 $24,761,985
Price (T.Rowe) Associates 2,997,269 $24,457,715
Franklin Resources, Inc 2,889,950 $23,581,992
Orbimed Advisors Inc. 2,826,500 $23,064,240
Wellington Management Company 1,963,800 $16,024,608
Deerfield Management 1,930,000 $15,748,800
Pequot Capital Management, Inc. 1,843,000 $15,038,880
FMR Corporation (Fidelity Management & Research Corp) 12,918,402 $105,414,160
Brinson Partners, Inc. 1,687,650 $13,771,224

Topliste der investierten Fonds
Fidelity Growth Company Fund 4,406,200 $35,954,592
Fidelity Aggressive Growth Fund 2,199,500 $17,947,920
Fidelity Select Portfolios - Biotechnology 1,974,100 $16,108,656
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 1,606,960 $13,112,793
Eaton Vance Global Health Portfolio 1,600,000 $13,056,000
Franklin Strategic Series-Franklin Small-Mid Cap Growth Fd 1,181,000 $9,636,960
Variable Insurance Products Fd-Growth Portfolio 1,181,842 $9,643,830
Finex Fonds Bio Spezial 1,100,000 $8,976,000
Fidelity Advisor Equity Growth Fund 1,077,000 $8,788,320
Putnam Vista Fund 1,082,500 $8,833,200